PNTG is the ticker symbol for Pennant Group, Inc., a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks PNTG with AI-powered analysis, an AI quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is PNTG a good stock to buy?

13F Pro's AI ranking engine scores PNTG at 62.3/100, ranked #721 of 2,925 stocks on a composite quality score built from its SEC filings, covering profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for PNTG is available at https://13fpro.ai/company/PNTG. Not investment advice — review the underlying SEC filings before making any trade.

Where does 13F Pro source PNTG data?

All Pennant Group, Inc. fundamentals and ownership data come directly from SEC EDGAR. Pennant Group, Inc. files with the SEC under CIK 1766400. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

Pennant Group, Inc. PNTG

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #721 of 2,925TOP 25%

Why it scores 62 Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$297.98M

Quarter to Jun 30

Net income

$9.08M

Quarter to Jun 30

Free cash flow

$15.49M

Quarter to Jun 30

Operating margin

5.8%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026

$1.16B total

BlackRock, Inc.

$109.34M+8.9%

Van Berkom & Associates Inc.

$87.54M-11.2%

WASATCH ADVISORS LP

$69.10M+31.8%

Turtle Creek Asset Management Inc.

$63.35M+8.3%

VANGUARD CAPITAL MANAGEMENT LLC

$54.72MNew

PARADIGM CAPITAL MANAGEMENT INC/NY

$51.83M-0.4%

FMR LLC

$43.68M+7.2%

Provident Investment Management, Inc.

$34.70M-4.5%

GOLDMAN SACHS GROUP INC

$32.94M+41.2%

GEODE CAPITAL MANAGEMENT, LLC

$32.77M+5.3%

AMERIPRISE FINANCIAL INC

$32.32M+0.3%

STATE STREET CORP

$32.26M+8.6%

DIMENSIONAL FUND ADVISORS LP

$32.09M+6.5%

WELLINGTON MANAGEMENT GROUP LLP

$27.99M0.0%

Nuveen, LLC

$25.86M+0.7%

First Eagle Investment Management, LLC

$21.08M+32.4%

MORGAN STANLEY

$20.14M+2.4%

BOONE CAPITAL MANAGEMENT LLC

$19.06MNew

De Lisle Partners LLP

$18.75M0.0%

Eversept Partners, LP

$17.01M+47.4%

VICTORY CAPITAL MANAGEMENT INC

$15.95M-2.0%

Ophir Asset Management Pty Ltd

$15.40M-53.9%

Qube Research & Technologies Ltd

$14.17MNew

NORTHERN TRUST CORP

$13.90M-12.5%

Rhenman & Partners Asset Management AB

$13.73M+34.9%

See all 205 institutional holders →

What's Driving PNTG's Business? Latest 10-Q Breakdown

AI-extracted from the 10-Q filed 2026-08-05 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Biggest Revenue Drivers

Home Health and Hospice Services$237.4M+43.2% YoY

Higher admissions (up 62.3% total, 70.7% Medicare), increased average daily hospice census (up 40.1%), and 38 new agencies added.

Senior Living Services$60.2M+12.6% YoY

Improved average monthly revenue per occupied unit (+3.9%) and eight new communities acquired.

Biggest Revenue Drivers

Total revenue: $298.0M+35.8% YoY

Home Health and Hospice Services$237.4M+43.2% YoY

Higher admissions (up 62.3% total, 70.7% Medicare), increased average daily hospice census (up 40.1%), and 38 new agencies added.

Senior Living Services$60.2M+12.6% YoY

Improved average monthly revenue per occupied unit (+3.9%) and eight new communities acquired.

Largest Expense Items

Cost of services$242.6M+36.9% YoY

Increased volume from higher admissions and census; transition costs related to acquisitions.

General and administrative expense$21.6M+22.8% YoY

Increased payroll, incentives, and related benefits across the growing operations.

Rent—cost of services$13.4M+12.6% YoY

New operating leases for acquired home health, hospice, and senior living properties.

Margins: Operating margin improved to 5.8% from 5.3% despite acquisition-related transitional headwinds and transition services costs of $2.5M. Cost of services increased 60 basis points as a percentage of revenue to 81.4%, driven by higher cost patterns at newly acquired operations, partially offset by leverage gains in existing operations.

Watch Items from the Filing

Medicare and Medicaid revenue concentration: combined 64.3% of Q2 revenue; receivables from these programs 68.9% of total AR as of June 30, 2026.
CMS six-month moratorium on new Medicare enrollment for home health and hospice effective May 13, 2026; heightened scrutiny in Arizona, California, Georgia, Nevada, Oklahoma, Texas.
Transition services costs of $2.5M in Q2 (YTD $5.3M) related to UnitedHealth/Amedisys acquisition integration; expected to continue.
Proposed CY 2027 home health payment increase of only 2.4% and hospice increase of 2.3%; proposed Medicare enrollment restrictions and retroactive revocation rules expand CMS enforcement authority.
Debt increased to $198.5M from $175.0M YTD; available liquidity $145.6M; leverage ratio requires monitoring given acquisition pace.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →

Key Metrics

Revenue

Q2 2026

EDGAR

Net Income

Q2 2026

EDGAR

EPS (Diluted)

Q2 2026

EDGAR

Operating Margin

Q2 2026

EDGAR

ROIC

Q2 2026

EDGAR

Free Cash Flow

Q2 2026

EDGAR

Debt/Equity

Q2 2026

EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PNTG

Earnings Per Share

13fpro.ai/company/PNTG

Loading ratio trend…

About Pennant Group, Inc. (PNTG): stock profile, AI score and financials

Pennant Group, Inc. (PNTG) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PNTG at 62.3/100 on a composite quality score built from its SEC filings, placing it at rank #721 of 2,925 stocks — the top 25% of the AI-ranked universe. PNTG scores in the top quartile across revenue growth (89.9), institutional flow (81.0), earnings quality (78.2). Areas of concern include free cash flow (36.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Pennant Group, Inc. reports quarterly revenue of $298.0M, net income of $9.1M, an operating margin of 5.8%. Top institutional holders of PNTG by reported 13-F value include BlackRock, Van Berkom & Associates, WASATCH ADVISORS, based on the most recent SEC filings. PNTG trades on the Nasdaq exchange and files with the SEC under CIK 1766400. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PNTG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pennant Group, Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1766400 →

Pennant Group, Inc. PNTG

Top Institutional Holders

What's Driving PNTG's Business? Latest 10-Q Breakdown

Biggest Revenue Drivers

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

Companies similar to PNTG

PNTG insiders

About Pennant Group, Inc. (PNTG): stock profile, AI score and financials